Pharmaceutical Industry

A businessman whose name appeared in Assad-era investigation documents concerning the use of pharmaceutical ingredients in the manufacture of Captagon has obtained a new license to operate in Syria’s pharmaceutical sector. Documents reviewed as part of this investigation reveal a network that allegedly used pharmaceutical factories and warehouses as a cover to divert regulated chemical substances, relying on fraudulent invoices and falsified commercial records to move controlled materials through the supply chain.